Radnet Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Radnet Inc in the second quarter 2026?
Radnet Inc achieved a return on average equity (ROE) of 1.42 % in its second quarter 2026, which is below Radnet Inc 's average return on equity, which stands at 61.24%.

ROE fell compared to the first quarter 2026, despite the net income growth of % from the first quarter 2026.

Within the Medical Laboratories industry 11 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 2224, from total ROE ranking in the first quarter 2026 at 2587.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Equity Change	18.21 %	19.02 %	19.63 %	17.36 %	-
Y / Y Net Income Change	-12.07 %	-	-30.68 %	13.32 %	231.66 %
Net Income (TTM) in Millions	19	22	17	21	20
Return On Equity (TTM)	1.42 %	1.7 %	1.37 %	1.8 %	1.73 %
RDNT's Total Ranking	# 2224	# 2587	# 2225	# 2225	# 2332
Equity (TTM) in Millions	1,394	1,353	1,356	1,314	1,179
Seq. Equity Change	3.06 %	-0.23 %	3.19 %	11.42 %	3.76 %
Seq. Net Income Change	-	-	-29 %	-39.7 %	-

Back to RDNT Management Effectiveness >> RDNT's 5 Years Annual ROE >> Compare RDNT ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 12
Sector	# 183
Overall	# 2224

Return On Equity Statistics
High	Average	Low
1827.69 %	61.24 %	-3.2 %
(Dec 31 2013)		(Mar 31 2018)

RDNT Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	1,356	1,133	813	491	346
Y / Y Equity Change	19.63 %	39.35 %	65.5 %	41.97 %	34.01 %
Net Income in Millions	17	39	30	34	44
Y / Y Net Income Change	-56.11 %	28.02 %	-9.73 %	-24.17 %	-
Return On Equity	1.26 %	3.43 %	3.73 %	6.84 %	12.8 %

Back to RDNT Management Effectiveness >> RDNT's 5 Years Annual ROE >> Compare RDNT ROE to its Competitors

Annual Roe Comment

In 2025 ROE decreased compared to the previous year to 1.26 %, due to deterioration of net income.

More Return On Equity Ratios
Medical Laboratories Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
RDNT's' Return on Equity at Yahoo Finance
RDNT's Roe Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for RDNT's Competitors
Subscribers only: Roe for Radnet Inc 's Suppliers
Subscribers only: Return On Equity for RDNT's Customers

Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector	ROE
Becton Dickinson And Company	3.79 %
Alkermes Plc	3.72 %
Lifemd Inc	3.47 %
Lifestance Health Group Inc	3.39 %
Revvity Inc	3.27 %
Bio rad Laboratories Inc	3.15 %
Envista Holdings Corporation	3.08 %
Immucell Corporation	2.68 %
Surgery Partners Inc	2.63 %
Mimedx Group Inc	2.61 %
Cormedix Inc	2.18 %
Atricure Inc	2.14 %
Pacira Biosciences inc	2.13 %
Warby Parker Inc	2.06 %
Repligen Corp	1.98 %
Arvinas Inc	1.91 %
Waters Corporation	1.88 %
Omada Health Inc	1.84 %
Radnet Inc	1.42 %
Icu Medical Inc	1.41 %
Biomarin Pharmaceutical Inc	1.18 %
Staar Surgical Co	1.08 %
Champions Oncology Inc	0.94 %
Delcath Systems Inc	0.46 %

Date modified: 2026-09-26T07:16:15+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.